With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Pharmaceutical Technology® Group spoke with Erik Wiklund, CEO of Circio, about the future of M&A in the bio/pharmaceutical industry and the struggle small biotech companies face raising funds.

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

Potential US tariffs add urgency to the EU’s pharma regulation debate, balancing industry calls for innovation against ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

Indian scientists evaluated two HPV kits, which have now been rolled out as a step forward in combating cervical cancer, the ...